Related Experiment Video
Updated: Mar 23, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut
L Baglatzi1, S Gavrili1, K Stamouli1
1Neonatal Department, Alexandra Hospital, University of Athens, Greece.
Insights
Supplementing infant formula with a low dose of Bifidobacterium lactis (B. lactis) probiotic showed similar immune and gut development benefits as a regular dose or breast milk. This supports the use of lower probiotic doses in infant formula for C-section born infants.
Area of Science:
- Pediatric Nutrition
- Microbiology
- Immunology
Background:
- Infant formula (IF) supplementation with probiotics aims to support immune functions and gut development in infants not breast-fed.
- The probiotic Bifidobacterium lactis CNCM I-3446 (B. lactis) is commonly used in regular doses (10^7 CFU/g).
Purpose of the Study:
- To evaluate if a low dose (10^4 CFU/g) of B. lactis in starter IF can achieve similar immune benefits as a regular dose.
- To compare the effects of low-dose and regular-dose B. lactis IF with breast milk in C-section delivered infants.
Main Methods:
- A pilot, prospective, double-blind, randomized clinical trial involving 77 infants per group receiving either low-dose or regular-dose B. lactis IF from birth to six months.
- A reference group of 44 breast-fed infants (minimum 4 months) was included.
- Assessments included gastrointestinal infections, immune and gut maturation, vaccination responses, and growth from birth to 12 months.
Main Results:
- Low-dose B. lactis IF demonstrated comparable effects to regular-dose B. lactis IF and breast milk.
- No significant differences were observed in gastrointestinal protection, immune/gut maturation, microbiota, or growth between the formula groups and the breast-fed group.
Conclusions:
- Supplementing C-section born neonates with low-dose B. lactis starter formula may promote immune and gut maturation comparable to regular-dose B. lactis and breast milk.
- This suggests that lower probiotic concentrations in infant formula can be effective.
Background:
In the absence of breast-feeding and its immunomodulatory factors, supplementation of starter infant formula (IF) with probiotics is currently used to support immune functions and gut development.
Aim:
To assess whether immune-related beneficial effects of regular dose (10(7) CFU/g of powder) of the probiotic Bifidobacterium lactis CNCM I-3446 (hereafter named B. lactis) in starter IF supplementation can be maintained with starter IF containing a low dose (10(4) CFU/g of powder) of B. lactis.
Method:
This trial was designed as a pilot, prospective, double-blind, randomized, single-center clinical trial of two parallel groups (n = 77 infants/group) of C-section delivered infants receiving a starter IF containing either low dose or regular dose of the probiotic B. lactis from birth to six months of age. In addition, a reference group of infants breast-fed for a minimum of four months (n = 44 infants), also born by C-section, were included. All groups were then provided follow-up formula without B. lactis up to 12 months of age. Occurrence of diarrhea, immune and gut maturation, responses to vaccinations, and growth were assessed from birth to 12 months. The effect of low-dose B. lactis formula was compared to regular-dose B. lactis formula, considered as reference for IF with probiotics, and both were further compared to breast-feeding as a physiological reference.
Results:
Data showed that feeding low-dose B. lactis IF provides similar effects as feeding regular-dose B. lactis IF or breast milk. No consistent statistical differences regarding early life protection against gastrointestinal infections, immune and gut maturation, microbiota establishment, and growth were observed between randomized formula-fed groups as well as with the breast-fed reference group.
Conclusion:
This pilot study suggests that supplementing C-section born neonates with low-dose B. lactis-containing starter formula may impact immune as well as gut maturation similarly to regular-dose B. lactis, close to the breast-feeding reference.
More Related Videos
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Probiotics
Gut-Brain Axis
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

